TotalMarketCap

Alpha Teknova

TKNONasdaq United StatesHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$484.920 M

$7.86 +6.63%

Close of 6 Nov 2026

As of 6 Nov 2026, Alpha Teknova (TKNO) has a market capitalization of $484.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$40.5M

#2781 by revenue

Earnings

-$17.3M

Loss-making

Shares outstanding

62,903,130

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →
  1. #9Myriad GeneticsMYGN$597.3M
  2. #10Anbio BiotechnologyNNNN$529.5M
  3. #11Alpha TeknovaTKNO$484.9M
  4. #12ImmucellICCC$89.7M
  5. #13Insight Molecular DiagnosticsIMDX$79.2M

What if Alpha Teknova were worth as much as…

Open the what-if tool →

Gold $28.2T

$457,629.08

Per share 58,230× higher

Bitcoin $1.53T

$24,761.51

Per share 3,151× higher

Apple $5.02T

$81,289.73

Per share 10,344× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Alpha Teknova are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.